Health Canada is readying itself to start testing the effects of inhaling substances emitted from cannabis vape products that recently hit legal retail shelves in Canada.

The federal regulator told CBC News that while it already has “research underway” on the effects of nicotine vapes, it plans to expand its “laboratory capability” to include the testing of cannabis vaporizers and related products.

Commercial real estate owners aren’t as high on cannabis legalization as they had hoped they’d be.

More than a year after cannabis was legalized in Canada, some analysts say the sometimes overhyped economic potential of the pot industry also infected B.C.’s real estate market.

As the country closed in on the legalization date last year, many in the real estate industry were excited about potential sales and investment opportunities. For realtors, cannabis legalization meant additional production facilities and retail spaces to sell or lease. However, that boom has yet to materialize.

Often, when analysts or bloggers talk up the potential of marijuana stocks, the focus is on the consumer side of the industry. But some of the best stocks in the pot sector may be medical marijuana stocks.

The Canadian government may have legalized cannabis, but its efforts to destigmatize the drug could use some work.

A statement from federal Minister of Health Patty Hajdu Thursday regarding the impending arrival of edibles is raising eyebrows for the language being used to describe cannabis compared to alcohol.

“The best way for Canadians to protect their health is not to consume cannabis, and adults who choose to use cannabis should avoid products from illegal or unknown sources,” Hajdu said.

The past six months for marijuana stocks have been less than stellar for most companies. Many have stated that the recession amongst cannabis companies, maybe over at this point in time. This means that some companies could be picked up for bare-bottom prices. One of the things to note about looking for marijuana stocks to buy is that the market is still very young. This shows that despite some companies having a large amount of intrinsic value, trading is still done off of speculation.

Read entire article here.

Cannabis 2.0 has become a major buzz word for the cannabis industry and this is an opportunity that we are excited about. The term refers to how the Canadian cannabis market is changing with the legalization of cannabis derivative products.

This represents a massive opportunity for cannabis producers and brands in Canada and we have been highly focused on this vertical. During the last year, we have seen a substantial increase in the number of companies that are levered to this market and this is something that investors need to be aware of.

Cannabis use among Canadian university students is on the rise, but St. Francis Xavier and Bishop have retained their crowns as the two highest standouts in 2019, notes the most recent annual survey from Maclean’s.

The more than 18,000 students who participated in the survey reported higher rates of cannabis use in 2019 than the students who took part the prior year.

The top pot-smoking schools for the second year in a row — aka, your best bet for a higher education — are St. Francis Xavier in Nova Scotia and Bishop’s in Quebec, with 65.5 percent and 61.8 percent, respectively, reporting that they consume cannabis at least once a year.

Medical and wellness dominate reasons for surveyed Canadians who consume cannabis, say findings of a newly released study representing 1,000 Canadians.

Nine out of 10 respondents cited “medical and/or wellness” as a driving component or their sole reason for cannabis consumption, although a significant number shied away from intoxicating products, notes a statement from Canadian PR and public affairs firm Hill+Knowlton Strategies (H+K).

The survey sample was provided by Leger Opinion (LEO) online panel, although H+K fielded the survey on their feedback platform. It offers new perspectives into the habits, behaviours and attitudes of individuals towards cannabis in the country.

Two Canadian companies have been approved as the first suppliers to the recently launched medical cannabis program in Ireland.

The Irish Government signed off on the launch of its five-year pilot in June, and now Aurora and MGC Pharmaceuticals have been selected to provide its first cannabis medicine.

Canadians bought nearly 100 tonnes of legal recreational cannabis in its first year of availability, while inventory levels continued to rise, new figures from Health Canada show.

Health Canada said 88,676 kilograms of dried flower cannabis was sold in Canada in the first year of legalization, according to its monthly Cannabis Tracking System. Overall sales of legal dried cannabis by weight have nearly tripled since October of 2018.